Naltrexone is an FDA-approved opioid antagonist used to treat alcohol use disorder and opioid dependence. Naltrexone blocks the effect of opioids and prevents opioid intoxication and physiologic dependence on opioid users. This medication is a mu-opioid receptor antagonist and also a weaker antagonist of the kappa and delta-opioid receptors. This activity is designed to improve the knowledge of competency of practitioners selecting naltrexone as part of the individualized approach for patients with alcohol or opioid use disorder. Naltrexone’s indications, mechanism of action, pharmacokinetics, administration methods, significant adverse effects, contraindications, monitoring, warnings, and toxicity are discussed.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/25519
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours
Social Work: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
ABIM - 1.0 Point; Credit Type(s): Patient Safety (ABIM) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Bariatric Surgery, Chemical Pathology, Developmental-Behavioral Pediatrics, Endocrinology, Diabetes, and Metabolism, Gastroenterology, General Pediatrics, Hospital Medicine, Internal Medicine
Subscribe
Login
0 Comments
Oldest